WATSON PHARMACEUTCLS (WPI)

Healthcare: Drugs - Generic

Brokerage Ratings
Closing price on 12/31/2009: $39.61
Filers holding this stock on 12/31/2009: 303
Aggregate shares on 12/31/2009: 93,186,092
Aggregate shares on 09/30/2009: 87,486,424
Percent change: 6.514917%
View insider trading info since Jan. 1 2008
Quarter 1: Quarter 2:
Brokerage Ratings on this stock:
Positive:
7
Neutral:
6
Negative:
2
Brokerage Date Issued Rating Price Target
NEEDHAM 01/24/2010 UNDERPERFORM
PIPER JAFFRAY 12/13/2009 UNDERWEIGHT $34.00
SUN TRUST RBSN HUMPHREY 12/10/2009 BUY $46.00
JP MORGAN 12/08/2009 NEUTRAL
RBC CAPITAL MKTS 05/03/2009 OUTPERFORM $39.00
CREDIT SUISSE 02/25/2009 NEUTRAL
CITIGROUP 02/17/2009 HOLD $34.00
STANFORD RESEARCH 01/22/2009 BUY $31.00
WACHOVIA 09/22/2008 OUTPERFORM
ROTH CAPITAL 02/25/2008 BUY $38.00
LEHMAN BROTHERS 02/21/2008 EQUAL-WEIGHT $33.00
WR HAMBRECHT 02/19/2008 BUY
BANC OF AMERICA SEC 12/18/2007 NEUTRAL $31.00
UBS 05/02/2007 BUY $37.00
GOLDMAN SACHS 03/26/2007 NEUTRAL
Schedule 13d filings involving this stock
Filing Company Subject Company Date of Filing
View Schedule 13D QUIVER INC. WATSON PHARMACEUTCLS 12/14/2009
Non-derivative Insider Transactions
Transaction Date Owner Shares Purchased/Sold Edgar filing
12/10/2009
EBERT CHARLES D
 0 View Filing
12/10/2009
MIRANDA DIANE F
 0 View Filing
12/10/2009
TURNER ANDREW L
 0 View Filing
12/16/2009
GIORDANO THOMAS R
 0 View Filing